166 related articles for article (PubMed ID: 1751644)
1. Regional distribution of brain gangliosides in Alzheimer's disease.
Kalanj S; Kracun I; Rosner H; Cosović C
Neurol Croat; 1991; 40(4):269-81. PubMed ID: 1751644
[TBL] [Abstract][Full Text] [Related]
2. Brain gangliosides in Alzheimer's disease.
Kracun I; Kalanj S; Cosovic C; Talan-Hranilovic J
J Hirnforsch; 1990; 31(6):789-93. PubMed ID: 2092064
[TBL] [Abstract][Full Text] [Related]
3. Human brain gangliosides in development, aging and disease.
Kracun I; Rosner H; Drnovsek V; Heffer-Lauc M; Cosović C; Lauc G
Int J Dev Biol; 1991 Sep; 35(3):289-95. PubMed ID: 1814411
[TBL] [Abstract][Full Text] [Related]
4. Cortical distribution of gangliosides in Alzheimer's disease.
Kracun I; Kalanj S; Talan-Hranilovic J; Cosovic C
Neurochem Int; 1992 Apr; 20(3):433-8. PubMed ID: 1304338
[TBL] [Abstract][Full Text] [Related]
5. Genotype-related changes of ganglioside composition in brain regions of transgenic mouse models of Alzheimer's disease.
Barrier L; Ingrand S; Damjanac M; Rioux Bilan A; Hugon J; Page G
Neurobiol Aging; 2007 Dec; 28(12):1863-72. PubMed ID: 17007963
[TBL] [Abstract][Full Text] [Related]
6. Differences in cerebrospinal fluid gangliosides between "probable Alzheimer's disease" and normal aging.
Blennow K; Davidsson P; Wallin A; Fredman P; Gottfries CG; Månsson JE; Svennerholm L
Aging (Milano); 1992 Dec; 4(4):301-6. PubMed ID: 1294245
[TBL] [Abstract][Full Text] [Related]
7. Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains.
Molander-Melin M; Blennow K; Bogdanovic N; Dellheden B; Månsson JE; Fredman P
J Neurochem; 2005 Jan; 92(1):171-82. PubMed ID: 15606906
[TBL] [Abstract][Full Text] [Related]
8. [Changes in cerebral gangliosides during long-term administration of amphetamine and haloperidol].
Shenk Kh; Khaumer U; Kharts S; Zikh M; Khasel'khorst U
Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(7):1021-5. PubMed ID: 3765985
[TBL] [Abstract][Full Text] [Related]
9. Ganglioside patterns in amyotrophic lateral sclerosis brain regions.
Rapport MM; Donnenfeld H; Brunner W; Hungund B; Bartfeld H
Ann Neurol; 1985 Jul; 18(1):60-7. PubMed ID: 4037752
[TBL] [Abstract][Full Text] [Related]
10. Topographical atlas of the gangliosides of the adult human brain.
Kraĉun I; Rösner H; Cosović C; Stavljenić A
J Neurochem; 1984 Oct; 43(4):979-89. PubMed ID: 6470716
[TBL] [Abstract][Full Text] [Related]
11. Gangliosides in rat kidney: composition, distribution, and developmental changes.
Saito M; Sugiyama K
Arch Biochem Biophys; 2001 Feb; 386(1):11-6. PubMed ID: 11360994
[TBL] [Abstract][Full Text] [Related]
12. Brain interleukin-1 beta in Alzheimer's disease and vascular dementia.
Cacabelos R; Alvarez XA; Fernández-Novoa L; Franco A; Mangues R; Pellicer A; Nishimura T
Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):141-51. PubMed ID: 8007743
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities in gangliosides and other lipids of monkey, rabbit and human brains with chronic organic mercury intoxication.
Ando S; Toyoda Y; Nagai Y; Ikuta F
Jpn J Exp Med; 1985 Feb; 55(1):1-6. PubMed ID: 3928950
[TBL] [Abstract][Full Text] [Related]
14. Gangliosides in the brain in adult Down's syndrome and Alzheimer's disease.
Brooksbank BW; McGovern J
Mol Chem Neuropathol; 1989 Dec; 11(3):143-56. PubMed ID: 2534985
[TBL] [Abstract][Full Text] [Related]
15. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
[TBL] [Abstract][Full Text] [Related]
16. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.
Beal MF; Mazurek MF; Svendsen CN; Bird ED; Martin JB
Ann Neurol; 1986 Oct; 20(4):489-95. PubMed ID: 3789664
[TBL] [Abstract][Full Text] [Related]
17. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
[TBL] [Abstract][Full Text] [Related]
18. Expression of cellular prion protein in the frontal and occipital lobe in Alzheimer's disease, diffuse Lewy body disease, and in normal brain: an immunohistochemical study.
Rezaie P; Pontikis CC; Hudson L; Cairns NJ; Lantos PL
J Histochem Cytochem; 2005 Aug; 53(8):929-40. PubMed ID: 16055747
[TBL] [Abstract][Full Text] [Related]
19. Ganglioside composition of an experimental mouse brain tumor.
Seyfried TN; Yu RK; Saito M; Albert M
Cancer Res; 1987 Jul; 47(13):3538-42. PubMed ID: 3581087
[TBL] [Abstract][Full Text] [Related]
20. Altered distribution of the gangliosides GM1 and GM2 in Alzheimer's disease.
Pernber Z; Blennow K; Bogdanovic N; Månsson JE; Blomqvist M
Dement Geriatr Cogn Disord; 2012; 33(2-3):174-88. PubMed ID: 22572791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
